25 Apr 2018 --- Novozymes has reported its first-quarter results with an overall sales growth of 2 percent, in line with company expectations. And the global biotechnology company is on track to deliver its full-year sales outlook of 4-6 percent. However, President and CEO Peder Holk Nielsen points to uncertainty in the agriculture-related business, citing “geopolitical tensions.”